A landmark decision by the Australian Financial Complaints Authority (AFCA) has overturned a long-standing assumption: that individuals cannot claim insurance payouts for complex illnesses diagnosed after their policy has ended. The ruling confirms that if symptoms of a condition appear while the insurance is active, and medical evidence later confirms the diagnosis, the policyholder—or their beneficiaries—remains entitled to compensation.
The case in question involved an individual who held a trauma insurance policy—a form of critical illness cover—between August 2011 and August 2020. During this period, the individual experienced several neurological issues, medically referred to as “neurological deficits.” At the time, however, the condition could not be definitively diagnosed.
Following the cancellation of the policy in 2020, the individual was formally diagnosed in February 2021 with Multiple Sclerosis (MS). When a claim was submitted to the insurer, Zurich rejected it, citing two reasons:
The disease was not diagnosed while the insurance was active.
The policy terms required a certain number of neurological impairments to be demonstrated, which were allegedly insufficient.
Upon appeal, AFCA thoroughly reviewed medical reports and expert opinions. A neurologist stated that the onset of the MS likely occurred in March or April 2019, well within the period when the policy was in force.
In its ruling, AFCA emphasised that early symptoms of MS are often vague and can be mistaken for common ailments. It would therefore be unreasonable to deny claims solely based on the formal date of diagnosis. The ombudsman added that nowhere in the policy does it stipulate that a diagnosis must occur while the insurance is active. What matters is whether the disease existed during the policy period.
Tragically, the original policyholder had passed away before the claim was resolved. The claim was pursued posthumously by the policyholder’s legal executor, and the decision was ultimately rendered in their favour. AFCA stated unequivocally:
“People do not take out insurance to know the name of the disease; they take it to protect themselves against the profound impact a disease can have on their life.”
Experts suggest that this decision will set a significant precedent for future claims involving long-term and slowly progressing illnesses, providing reassurance to policyholders and their families.
Key Case Details at a Glance
| Subject | Details |
|---|---|
| Type of Insurance | Trauma Cover (Critical Illness) |
| Policy Period | August 2011 – August 2020 |
| Diagnosis Date | February 2021 |
| Illness | Multiple Sclerosis (MS) |
| Probable Disease Onset | March–April 2019 |
| Ruling Authority | AFCA |
| Outcome | Insurer required to pay the claim |
This ruling underscores the principle that insurance is intended to protect against the real-life impact of serious illness, not merely to cover formally diagnosed conditions. It is expected to influence insurance claims and policy interpretation worldwide.